免疫球蛋白治疗格林巴利综合征的临床疗效分析  

Clinical Efficacy of Immunoglobulin Therapy Guillain-Barre Syndrome

作　　者：郭振委[1] 孙永安[1] 陶爱华[1] 何效兵[1] 

机构地区：[1]江苏省徐州医学院附属连云港市第一人民医院神经内科,江苏连云港222002

出　　处：《中国医药指南》2014年第35期60-61,共2页Guide of China Medicine

摘　　要：目的探讨分析免疫球蛋白治疗格林巴利综合征的临床疗效。方法选取我院2012年1月至2014年1月收治的60例格林巴利综合征患者,随机分为观察组与对照组,各30例。对照组患者给予综合治疗,观察组患者在综合治疗的基础上,给予免疫球蛋白静脉滴注治疗。观察对比两组患者的临床疗效、起效时间以及治疗前后的生活活动能力。结果观察组患者的治疗总有效率为96.7%,明显高于对照组的76.7%,组间对比差异明显(P<0.05),具有统计学意义;观察组患者的起效时间及治疗后的生活活动能力评分均要优于对照组,组间对比差异明显(P<0.05),具有统计学意义。结论免疫球蛋白治疗格林巴利综合征的效果更好,可以更快显效,提高了患者的生活活动能力,值得在临床治疗中推广应用。Objective To investigate the clinical effect of the treatment of analysis of immunoglobulin protein Green Barre syndrome. Methods Selected in our hospital in 2012 January to 2014 January were 60 cases of Green Barre syndrome patients, randomly divided into observation group and control group, each of 30 cases. Results In the observation of patients in the treatment group the total effective rate was 96.7%, significantly higher than the control group 76.7%, the comparison between the two groups （P〈0.05）, obvious difference has statistical significance; observing the onset time and the patients in the treatment group after the life ability scores were superior to the control group, the difference between groups than obviously （P〈0.05）, with statistical significance. Conclusion Better effects of immtmoglobulin treatment in Green Barre, faster effect, improve the patient＇s life activity, is worthy to be popularized in clinical treatment.

关 键 词：免疫球蛋白 格林巴利综合征 临床疗效 

分 类 号：R745.4[医药卫生—神经病学与精神病学]